Literature DB >> 15820999

Exercise testing to stratify risk in aortic stenosis.

Paul Das1, Helen Rimington, John Chambers.   

Abstract

AIMS: The aims of this study were to assess the accuracy of exercise testing in predicting symptom onset within 12 months in patients with asymptomatic aortic stenosis and to establish the criteria that define a positive test. METHODS AND
RESULTS: A total of 125 patients with aortic stenosis [effective orifice area (EOA) 0.9+/-0.2 cm2] were assessed by Specific Activity Scale (SAS) classification, transthoracic echocardiography, and treadmill exercise testing using the modified Bruce protocol. During follow-up, 36 patients (29%) developed spontaneous symptoms within 12 months. Of these, 26 (72%) had had symptoms revealed by exercise testing and 24 (67%) had severe stenosis (EOA < or = 0.8 cm2). Exercise-limiting symptoms were the only independent predictors of outcome at 12 months, and an abnormal blood pressure response or ST segment depression did not improve the accuracy of the exercise test. The positive predictive accuracy for exercise-induced symptoms was 57% in the whole population and 79% for patients aged <70 in SAS Class I. The negative predictive accuracy was 87% in the whole population and 86% in the subgroup.
CONCLUSION: A significant proportion of patients with apparently asymptomatic aortic stenosis experience limiting symptoms on treadmill exercise testing. The subsequent development of spontaneous symptoms is strongly related to the severity of stenosis and to limiting symptoms on exercise testing, but less so to an abnormal blood pressure response or ST segment depression.

Entities:  

Mesh:

Year:  2005        PMID: 15820999     DOI: 10.1093/eurheartj/ehi250

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  53 in total

Review 1.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

Review 2.  Low "gradient", low flow aortic stenosis.

Authors:  John Chambers
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

Review 3.  Stress testing in valve disease.

Authors:  Luc A Piérard; Patrizio Lancellotti
Journal:  Heart       Date:  2007-06       Impact factor: 5.994

Review 4.  Evaluation of aortic stenosis: an update--including low-flow States, myocardial mechanics, and stress testing.

Authors:  Luc A Pierard; Raluca Dulgheru
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

5.  Exercise stress echocardiography in patients with aortic stenosis: impact of baseline diastolic dysfunction and functional capacity on mortality and aortic valve replacement.

Authors:  Andrew N Rassi; Wael Aljaroudi; Sahar Naderi; M Chadi Alraies; Venu Menon; Leonardo Rodriguez; Richard Grimm; Brian Griffin; Wael A Jaber
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

Review 6.  Exercise hemodynamics in valvular heart disease.

Authors:  Anna M Booher; David S Bach
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

7.  [The "asymptomatic" patient with chronic acquired heart valve disease].

Authors:  D Horstkotte; C Prinz; C Piper
Journal:  Internist (Berl)       Date:  2013-01       Impact factor: 0.743

8.  Quality of life among patients with severe aortic stenosis.

Authors:  M W A van Geldorp; H J Heuvelman; A P Kappetein; J J V Busschbach; D J Cohen; J J M Takkenberg; A J J C Bogers
Journal:  Neth Heart J       Date:  2013-01       Impact factor: 2.380

Review 9.  Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment.

Authors:  Jean G Dumesnil; Philippe Pibarot; Blase Carabello
Journal:  Eur Heart J       Date:  2009-09-08       Impact factor: 29.983

10.  Management of asymptomatic severe aortic stenosis.

Authors:  Robert L Stewart; Kwan L Chan
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.